New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
14:27 EDTCTRX, CICatamaran weakness a buying opportunity, says Cowen
Cowen said weakness in Catamaran (CTRX) related to Cigna's (CI) decision to keep its PBM or not has not bearing on the company. The firm expects Cigna to keep the PBM but to contract out the back-end fulfillment services, which Catamaran is likely to get the rest of, while Cigna keeps the more profitable portion of the business in-house. Shares are Outperform rated.
News For CTRX;CI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
08:08 EDTCICigna management to meet with Deutsche Bank
Subscribe for More Information
06:44 EDTCTRXCatamaran management to meet with SunTrust
Meeting to be held in San Francisco on October 8 hosted by SunTrust.
September 30, 2014
07:34 EDTCICigna management to meet with Deutsche Bank
Meeting to be held in Frankfurt on September 30 hosted by Deutsche Bank.
September 29, 2014
08:22 EDTCICigna management to meet with Deutsche Bank
Subscribe for More Information
08:04 EDTCTRXCatamaran shares now pricing in aggressive estimates, says Jefferies
Jefferies believes aggressive 2015 consensus earnings expectations are now adequately reflected in shares of Catamaran following the recent pullback. The firm continues to believe M&A will be a driver of shares in the near-term and that an upside-driving deal announcement is imminent. It keeps a Buy rating on Catamaran with a $58 price target.
September 26, 2014
06:31 EDTCTRXCatamaran 'mega' deal likely over next few years, says Leerink
Subscribe for More Information
September 25, 2014
08:05 EDTCTRXCatamaran risk/reward compelling after pullback, says FBR Capital
FBR Capital attributes yesterday's weakness in shares of Catamaran to concerns from the consultant community regarding service issues and competition. The firm says its not aware of any "widespread" evidence pointing to performance issues at the company. It views the risk/reward scenario on shares of Catamaran as compelling and maintains an Outperform rating on the name.
September 24, 2014
06:45 EDTCIGovernment says more health insurers to enter exchanges in 2015, NY Times says
Subscribe for More Information
September 23, 2014
11:19 EDTCICigna, Virginia Quality Care Partners announce collaboration
Subscribe for More Information
07:54 EDTCTRXLeerink to hold a conference
Subscribe for More Information
07:38 EDTCTRXCantor to hold a conference
3rd Annual Technology Conference to be held in Toronto on September 23.
07:38 EDTCTRXCatamaran high EBITDA estimates could create overhang, says Credit Suisse
Subscribe for More Information
September 22, 2014
06:54 EDTCICigna removed from short-term buy list at Deutsche Bank
Subscribe for More Information
September 19, 2014
06:49 EDTCIGovernment says 7.3M in private Obamacare plans, NY Times reports
Subscribe for More Information
September 17, 2014
10:00 EDTCIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.
08:38 EDTCICigna upgraded to Positive from Neutral at Susquehanna
As previously reported, Susquehanna upgraded Cigna to Positive from Neutral. The firm believes Cigna's earnings are poised to accelerate driven by a reduction in ACA related losses, conservative medical cost ratio assumptions, buybacks, and normal business growth. Price target raised to $115 from $77.
07:06 EDTCICigna upgraded to Positive from Neutral at Susquehanna

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use